ALEXANDRIA, Va., Nov. 25 -- United States Patent no. 12,479,928, issued on Nov. 25, was assigned to MINERVA BIOTECHNOLOGIES Corp. (Waltham, Mass.).
"Anti-cancer peptide" was invented by Cynthia Bamdad (Waltham, Mass.) and Benoit Smagghe (Waltham, Mass.).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present application discloses anti-NME antibodies and their use in treating or preventing diseases."
The patent was filed on April 12, 2022, under Application No. 17/719,302.
*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=12479928&OS=1247992...